Antimicrobial Hernia Repair Device

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This prospective early feasibility clinical study will collect information regarding the safety and efficacy of the Cook® Antimicrobial Hernia Repair Device to reinforce soft tissue during ventral or incisional hernia repair in clean-contaminated and contaminated (i.e., Class II and Class III) surgical fields.

See also
Status	Clinical Trial	Phase
Completed	`NCT01183325` - Prospective Evaluation of the Proceed Ventral Patch With and Without Laparoscopic Evaluation	N/A
Completed	`NCT01673568` - Abdominal Binder to Reduce Pain and Seroma Formation	N/A
Completed	`NCT01962480` - The Effect of Laparoscopically Closing the Hernia Defect in Laparoscopic Ventral Hernia Repair on Postoperative Pain	N/A
Completed	`NCT01784822` - Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair	N/A

NCT number	NCT02730936
Study type	Interventional
Source	Cook
Contact
Status	Withdrawn
Phase	N/A
Start date	January 12, 2016
Completion date	July 2020

Antimicrobial Hernia Repair Device

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms